Elsevier Acquires Fisterra.Com, an E-Clinical Reference Solution for Spanish Primary Care Professionals

By Elsevier, PRNE
Sunday, May 8, 2011

MADRID, May 9, 2011 - Elsevier (www.elsevier.com), the leading global publisher of
scientific, technical, and medical information products and services,
announced today the acquisition of Fisterra.com, an award winning, widely
used e-clinical reference solution in Spain. Fisterra was launched in 2002 by
two primary care doctors and a medical librarian in response to the need for
an online short answer Spanish language reference solution to help primary
care physicians.

Fisterra.com provides access to Fisterrae, an advanced e-clinical
reference solution that integrates support resources for health professionals
in a local language platform. Fisterrae is written by doctors and pharmacists
and is kept permanently up to date by following medical journals, reviews by
the Cochrane Library and the most important databases of clinical practice

"Fisterra has been a trusted and integral partner to the Spanish medical
community so we're proud of this acquisition," said Claudia Pickholz,
Managing Director, Elsevier Spain. "By combining Fisterra's content with
Elsevier's Spanish and English language online reference materials we can
create a powerful e-clinical reference solution, provide useful and high
quality content for clinical decision making and add to our range of content
and support services for medical students and professionals."

Fisterra.com solutions include: clinical guides and protocols; a clinical
drug database with dosage calculators; a vaccination tool; electronic
continuing medical education content; and patient handouts. A mobile app
suitable for point of care contexts is also in development.

"With Elsevier's broad experience in content creation and review,
Fisterra.com will receive new consultation assets that satisfy the needs of
its professional customers," said Arturo Louro, one of Fisterra.com's
founders who will continue to consult for the site and serve on the product's
new advisor board.

The website will add to Elsevier's electronic services supported by the
most distinguished local authors, translations of major international
references, information and first-level knowledge to individuals and groups
engaged in quality health practice and research.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet (www.thelancet.com/) and Cell
(www.cell.com/), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
SciVerse ScienceDirect (www.sciencedirect.com/), SciVerse Scopus
(www.scopus.com/home.url), Reaxys (https://www.reaxys.com/info/), MD
Consult (www.mdconsult.com/php/241547652-53/homepage) and Nursing
Consult (
which enhance the productivity of science and health professionals, and the
SciVal suite and MEDai's Pinpoint Review (www.medai.com/), which help
research and health care institutions deliver better outcomes more

A global business headquartered in Amsterdam, Elsevier employs 7,000
people worldwide. The company is part of Reed Elsevier Group PLC, a
world-leading publisher and information provider, which is jointly owned by
Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext
Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock

    Media Contact
    Tom Reller
    VP, Corporate Relations, Elsevier

Media Contact: Tom Reller, VP, Corporate Relations, Elsevier, T.Reller at elsevier.com, +1-215-239-3508

will not be displayed